Ipragliflozin improved glycaemic control with additional benefits of reductions of body weight and blood pressure in Japanese patients with type 2 diabetes mellitus: BRIGHTEN Study

被引：0
|
作者：
Kashiwagi, A. [1 ]
Takinami, Y. [2 ]
Kazuta, K. [2 ]
Yoshida, S. [2 ]
Utsuno, A. [2 ]
Nagase, I. [2 ]
机构：
[1] Shiga Univ Med Sci, Tokyo, Japan
[2] Astellas Pharma Inc, Tokyo, Japan
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
149
引用
收藏
页码：S68 / S69
页数：2
相关论文
共 50 条
  • [21] Dimethylarginines in patients with type 2 diabetes mellitus: Relation with the glycaemic control
    Can, Ayten
    Bekpinar, Seldag
    Gurdol, Figen
    Tutuncu, Yildiz
    Unlucerci, Yesim
    Dinccag, Nevin
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 94 (03) : E61 - E64
  • [22] Efficacy and safety of sodium-glucose cotransporter 2 inhibitor ipragliflozin on glycemic control and cardiovascular parameters in Japanese patients with type 2 diabetes mellitus; Fukuoka Study of Ipragliflozin (FUSION)
    Nomiyama, Takashi
    Shimono, Dai
    Horikawa, Tsuyoshi
    Fujimura, Yuki
    Ohsako, Tomohiro
    Terawaki, Yuichi
    Fukuda, Takashi
    Motonaga, Ryoko
    Tanabe, Makito
    Yanase, Toshihiko
    Nawata, Hajime
    Takahashi, Hiroyuki
    Yanagida, Ikumi
    Ono, Junko
    Kogawa, Kazuhiko
    Muta, Kazuo
    Arase, Koichi
    Oba, Koichi
    Murase, Kunitaka
    Hamanoue, Nobuya
    Minezaki, Midori
    Imamura, Mitsuhide
    Yoshida, Ryoko
    Yatabe, Sakon
    Komatsu, Shiho
    Maruyama, Syunichiro
    Futata, Tetsuhiro
    Umei, Toshihiko
    Noda, Tomohiro
    Hyodo, Tomoko
    Tsutsumi, Yoko
    Takeda, Yumi
    Hatta, Yumiko
    Fukuda, Yusuke
    Fujihara, Yuya
    ENDOCRINE JOURNAL, 2018, 65 (08) : 859 - 867
  • [23] Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus
    Kothny, W.
    Foley, J.
    Kozlovski, P.
    Shao, Q.
    Gallwitz, B.
    Lukashevich, V.
    DIABETES OBESITY & METABOLISM, 2013, 15 (03): : 252 - 257
  • [24] A novel and selective SGLT2 inhibitor, tofogliflozin improves glycaemic control and lowers body weight in patients with type 2 diabetes mellitus
    Ikeda, S.
    Takano, Y.
    Cynshi, O.
    Christ, A. D.
    Boerlin, V.
    Beyer, U.
    Beck, A.
    DIABETOLOGIA, 2012, 55 : S316 - S316
  • [25] IMPROVEMENT OF DAILY GLYCEMIC PROFILE AND REDUCTION OF BODY WEIGHT WITH SGLT2 INHIBITOR IPRAGLIFLOZIN IN JAPANESE OBESE ADULTS WITH TYPE 2 DIABETES MELLITUS
    Kusama, M.
    Imamine, R.
    Kouchi, Y.
    Kawai, M.
    Minatoguchi, M.
    Mizoguchi, A.
    Watarai, A.
    Kanai, A.
    Kawamura, T.
    Hotta, N.
    Nakashima, E.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S5 - S5
  • [26] Weight gain is associated with improved glycaemic control but with adverse changes in plasma lipids and blood pressure in Type 1 diabetes
    Ferriss, JB
    Webb, D
    Chaturvedi, N
    Fuller, JH
    Idzior-Walus, B
    DIABETIC MEDICINE, 2006, 23 (05) : 557 - 564
  • [27] Efficacy and safety of adding ipragliflozin to insulin in Japanese patients with type 1 diabetes mellitus: a retrospective study
    Shimoda, Masashi
    Mashiko, Akiko
    Katakura, Yukino
    Sanada, Junpei
    Fushimi, Yoshiro
    Obata, Atsushi
    Kimura, Tomohiko
    Kohara, Kenji
    Tatsumi, Fuminori
    Nakanishi, Shuhei
    Mune, Tomoatsu
    Kaku, Kohei
    Kaneto, Hideaki
    ENDOCRINE JOURNAL, 2021, 68 (12) : 1455 - 1461
  • [28] Luseogliflozin (TS-071), a selective SGLT2 inhibitor, improves glycaemic control and lowers body weight in a 12-week study in Japanese patients with type 2 diabetes mellitus
    Seino, Y.
    Sasaki, T.
    Fukatsu, A.
    Samukawa, Y.
    Sakai, S.
    Watanabe, T.
    DIABETOLOGIA, 2012, 55 : S303 - S303
  • [29] Cost-effectiveness analysis of improved blood pressure control of hypertensive patients with Type 2 diabetes mellitus
    Samira, HH
    Lahiry, S
    Howlader, SR
    Parveen, S
    Khan, AKA
    DIABETOLOGIA, 2004, 47 : A50 - A50
  • [30] Effect of Meat Consumption on the Glycaemic Control, Obesity and Blood Pressure in Patients with Type 2 Diabetes
    Dutt, Aswini R.
    Kumar, Satish N. S.
    Bhat, Shankar K.
    Bhat, M. Bhima
    S'ouza, Neevan D. R. D.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2012, 6 (03) : 441 - 444
12345